54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 08
11:28 UTC
|
CARG
CarGurus
|
◎ Target | Chris Pierce ★☆☆☆☆ #3146 | Buy | $43.00→ $44.00+2.3% |
|
Aug 08
11:28 UTC
|
CACI
CACI International
|
◎ Target | Gavin Parsons ★★★☆☆ #1654 | Buy | $598.00→ $804.00+34.4% |
|
Aug 08
11:28 UTC
|
CACI
CACI International
|
◎ Target | Seth Seifman ★★☆☆☆ #2609 | Overweight | $645.00→ $715.00+10.9% |
|
Aug 08
11:28 UTC
|
CABO
Cable One
|
◎ Target | Gregory Williams ★☆☆☆☆ #3064 | Hold | $111.00→ $86.00-22.5% |
|
Aug 08
11:28 UTC
|
BTMD
biote
|
◎ Target | Jonna Kim ★★★★★ #276 | Buy | $2.50→ $2.00-20.0% |
|
Aug 08
11:28 UTC
|
BSY
Bentley Systems
|
◎ Target | firm only | Outperform | $41.00→ $43.00+4.9% |
|
Aug 08
11:28 UTC
|
BP
BP
|
◎ Target | John Royall not yet tracked | Neutral | $42.00→ $43.00+2.4% |
|
Aug 08
11:28 UTC
|
BOS
AirBoss of America
|
◎ Target | firm only | Buy | C$10.00→ C$11.00+10.0% |
|
Aug 08
11:28 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Mitchell S. Kapoor not yet tracked | Neutral | $50.00→ $60.00+20.0% |
|
Aug 08
11:28 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Leland Gershell ★☆☆☆☆ #3004 | Outperform | $95.00→ $97.00+2.1% |
|
Aug 08
11:28 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Matthew Harrison not yet tracked | Overweight | $119.00→ $124.00+4.2% |
|
Aug 08
11:28 UTC
|
BMBL
Bumble
|
◎ Target | Brad Erickson ★★★☆☆ #1886 | Sec→ r Perform | $5.00→ $4.00-20.0% |
|
Aug 08
11:28 UTC
|
BMBL
Bumble
|
◎ Target | Ken Gawrelski ★★★☆☆ #1080 | Equal Weight | $5.00→ $4.00-20.0% |
|
Aug 08
11:28 UTC
|
BMBL
Bumble
|
◎ Target | Shyam Patil ★★★☆☆ #1208 | Neutral | $3.50→ $3.00-14.3% |
|
Aug 08
11:28 UTC
|
BLNK
Blink Charging
|
◎ Target | Sameer Joshi ★★☆☆☆ #2911 | Buy | $2.50 |
|
Aug 08
11:28 UTC
|
BLND
Blend Labs
|
◎ Target | Michael Turrin ★★★☆☆ #1136 | Overweight | $4.00→ $3.00-25.0% |
|
Aug 08
11:28 UTC
|
BETR
Better Home & Finance
|
◎ Target | Kyle Peterson ★★★☆☆ #1854 | Buy | $35.00→ $25.00-28.6% |
|
Aug 08
11:28 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Kendall Au not yet tracked | Sec→ r Perform | $175.00→ $180.00+2.9% |
|
Aug 08
11:28 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Joanna Wiensch not yet tracked | Buy | $198.00→ $204.00+3.0% |
|
Aug 08
11:28 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Lawrence Biegelsen not yet tracked | Equal Weight | $161.00→ $170.00+5.6% |
|
Aug 08
11:28 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Jason Bednar ★★★★☆ #362 | Neutral | $161.00→ $175.00+8.7% |
|
Aug 08
11:28 UTC
|
BCH
Banco De Chile
|
◎ Target | Yuri Fernandes ★☆☆☆☆ #2972 | Neutral | $42.00→ $45.00+7.1% |
|
Aug 08
11:28 UTC
|
BCE
BCE
|
◎ Target | firm only | Sec→ r Outperform | C$39.00→ C$40.00+2.6% |
|
Aug 08
11:28 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$43.50→ C$41.00-5.7% |
|
Aug 08
11:28 UTC
|
BATRK
Atlanta Braves
|
◎ Target | Barton Crockett ★★★★☆ #757 | Buy | $75.00→ $73.00-2.7% |
|
Aug 08
11:28 UTC
|
AVTX
Avalo Therapeutics
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $35.00→ $30.00-14.3% |
|
Aug 08
11:28 UTC
|
AVPT
AvePoint
|
◎ Target | Derrick Wood ★★★★☆ #423 | Buy | $14.00→ $15.00+7.1% |
|
Aug 08
11:28 UTC
|
AVNT
Avient
|
◎ Target | Abigail Eberts not yet tracked | Overweight | $47.00→ $48.00+2.1% |
|
Aug 08
11:28 UTC
|
AVNT
Avient
|
◎ Target | Peter Osterland not yet tracked | Buy | $44.00→ $50.00+13.6% |
|
Aug 08
11:28 UTC
|
AUPH
Aurinia Pharmaceuticals
|
◎ Target | Douglas Miehm ★★★☆☆ #1105 | Sec→ r Perform | $15.00→ $16.00+6.7% |
|
Aug 08
11:28 UTC
|
ATS
ATS
|
◎ Target | firm only | Buy | C$52.00→ C$44.00-15.4% |
|
Aug 08
11:28 UTC
|
ATS
ATS
|
◎ Target | firm only | Buy | C$52.00→ C$46.00-11.5% |
|
Aug 08
11:28 UTC
|
ATS
ATS
|
◎ Target | firm only | Outperform | C$46.00→ C$33.00-28.3% |
|
Aug 08
11:28 UTC
|
ATS
ATS
|
◎ Target | firm only | Outperform | C$57.00→ C$42.00-26.3% |
|
Aug 08
11:28 UTC
|
ATI
ATI
|
◎ Target | Andre Madrid ★★☆☆☆ #2877 | Buy | $180.00→ $270.00+50.0% |
|
Aug 08
11:28 UTC
|
ATI
ATI
|
◎ Target | Charles Minervino ★★☆☆☆ #2406 | Positive | $215.00→ $265.00+23.3% |
|
Aug 08
11:27 UTC
|
ASTH
Astrana Health
|
◎ Target | Andrew Mok not yet tracked | Overweight | $50.00→ $53.00+6.0% |
|
Aug 08
11:27 UTC
|
ARW
Arrow Electronics
|
◎ Target | William Stein ★★☆☆☆ #2586 | Buy | $260.00→ $250.00-3.8% |
|
Aug 08
11:27 UTC
|
ARW
Arrow Electronics
|
◎ Target | Joseph Quatrochi ★★☆☆☆ #2581 | Underweight | $175.00→ $200.00+14.3% |
|
Aug 08
11:27 UTC
|
ARLO
Arlo Technologies
|
◎ Target | James Fish ★★★☆☆ #1458 | Overweight | $17.00→ $18.00+5.9% |
|
Aug 08
11:27 UTC
|
ARHS
Arhaus
|
◎ Target | Cristina Fernandez ★★★☆☆ #1188 | Market Perform | $8.00→ $10.00+25.0% |
|
Aug 08
11:27 UTC
|
ARHS
Arhaus
|
◎ Target | Peter Keith ★★★★☆ #558 | Neutral | $8.00→ $9.00+12.5% |
|
Aug 08
11:27 UTC
|
ARHS
Arhaus
|
◎ Target | Simeon Gutman ★★★★☆ #401 | Equal Weight | $9.00→ $10.00+11.1% |
|
Aug 08
11:27 UTC
|
ARDX
Ardelyx
|
◎ Target | Joseph Thome ★★☆☆☆ #2811 | Buy | $13.00→ $10.00-23.1% |
|
Aug 08
11:27 UTC
|
ARDX
Ardelyx
|
◎ Target | Julian Harrison ★★☆☆☆ #2841 | Buy | $17.00→ $14.00-17.6% |
|
Aug 08
11:27 UTC
|
APPN
Appian
|
◎ Target | Sanjit Singh ★★★☆☆ #1479 | Equal Weight | $25.00→ $32.00+28.0% |
|
Aug 08
11:27 UTC
|
APPN
Appian
|
◎ Target | Steven Enders not yet tracked | Buy | $37.00→ $40.00+8.1% |
|
Aug 08
11:27 UTC
|
APP
AppLovin
|
◎ Target | Jason Bazinet ★★☆☆☆ #2640 | Buy | $710.00→ $650.00-8.5% |
|
Aug 08
11:27 UTC
|
AMPL
Amplitude
|
◎ Target | Tyler Radke ★★★★☆ #373 | Neutral | $10.00→ $11.00+10.0% |
|
Aug 08
11:27 UTC
|
AMPH
Amphastar Pharmaceuticals
|
◎ Target | Benjamin Burnett ★★★☆☆ #1809 | Equal Weight | $19.00→ $20.00+5.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.